Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Works in Cardiovascular · Dermatology · Hematology · Immunology · Musculoskeletal · Neurology · Oncology · Renal & urogenital · Women's health
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company is a clinical trial sponsor. It has 15 active clinical trials with 2,869 planned participants, across 9 therapeutic areas. Since 2021 it has completed 0 trials and stopped 2 early.
Trial track record · since 2021
Pipeline · 15 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company is lead sponsor of 15 active clinical trials on ClinicalTrials.gov, with 2,869 planned participants, in Cardiovascular, Dermatology, Hematology, Immunology and other areas. Since 2021 it has completed 0 trials and stopped 2 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Juno Therapeutics, Inc., a Bristol-Myers Squibb Company; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-06.
Approve Suite is not affiliated with Juno Therapeutics, Inc., a Bristol-Myers Squibb Company.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.